Dermatology
Conference Coverage
Triple-combination for severe acne avoids isotretinoin
Major Finding: Eighty percent of patients with acne sufficiently severe that blinded evaluators judged them to be candidates for isotretinoin at...
Commentary
Nanoparticles take aim at acne
News
Newly labeled sunscreens surface on shelves
Conference Coverage
Combo may be best rescue therapy for resistant Kawasaki disease
Major Finding: Nonresponders to IVIG plus aspirin for treatment of acute Kawasaki disease were significantly more likely to respond to rescue...
Conference Coverage
Acne 101: Educate Patients Before Topical Therapy
Conference Coverage
Limit Oral Acne Antibiotics to 3 Months
Conference Coverage
Tacrolimus 0.03% Favored for Atopic Blepharoconjunctivitis
Major Finding: The conjunctivitis response rates were 80%, 55%, and 50% with tacrolimus, pimecrolimus, and topical steroids, respectively.
Conference Coverage
New Acne Treatment to Hit U.S. Market
Conference Coverage
Propanolol Guidelines for Infant Hemangiomas Focus on Hospitalization
Conference Coverage
Even Simple Exanthems Warrant Thorough Evaluation
Conference Coverage
Pimecrolimus Shines in Large Infant Atopy Study
Major Finding: After 5 years of participation in a study of pimecrolimus- versus topical corticosteroid-based treatment strategies for infants...